ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation (NEXIRI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00989469
Recruitment Status : Completed
First Posted : October 5, 2009
Last Update Posted : February 10, 2012
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Institut du Cancer de Montpellier - Val d'Aurelle